Acute Topics in Anti-Doping

Description

Doping represents the dark side of amateur and professional sports – in order to protect athletes around the globe, anti-doping rules are continuously revised and improved. This publication reviews the current regulatory framework, scientific aspects, future approaches, and social and ethical dimensions of the fight against doping in sport. Prominent experts on the implementation of anti-doping strategies, as well as leading researchers in science and medicine, have contributed to this publication. In keeping with its interdisciplinary origin, the book is intended for athletes, coaches, students, scientists, anti-doping officials, and all others interested in anti-doping and sports. Ranging from legal and educational to scientific and medical issues, this collection emphasizes the need for a multidisciplinary approach and the importance of preventative strategies in the fight against doping in sports.

Informations

• Publié par: S. Karger AG
• Date de parution: 02 juin 2017
• Nombre de lectures: 0
• EAN13: 9783318060447
• Langue: English
• Poids de l'ouvrage: 2 Mo

Extrait

Acute Topics in Anti-Doping
Medicine and Sport Science
Vol. 62
Series Editors
Dennis J. Caine Georgetown, TX
Andrew P. Hills Brisbane, QLD
Timothy Noakes Cape Town
Acute Topics in Anti-Doping
Volume Editors
Olivier Rabin Montreal, QC
Yannis Pitsiladis Eastbourne
15 figures, 8 in color, and 9 tables, 1 in color, 2017
Medicine and Sport Science
Founded 1968 by E. Jokl, Lexington, KY
Honorary Series Editors: J. Borms, Brussels; M. Hebbelinck, Brussels
_______________________ Olivier Rabin, PhD Senior Executive Director, Sciences and International Partnerships World Anti-Doping Agency (WADA) Stock Exchange Tower 800 Place Victoria, Suite 1700 Montreal, QC H4Z 1B7 (Canada)
_______________________ Yannis Pitsiladis, MMedSci, PhD, FACSM Professor of Sport and Exercise Science University of Brighton Welkin House 30 Carlisle Road Eastbourne BN20 7SN (UK)
Library of Congress Cataloging-in-Publication Data
Names: Rabin, Olivier, editor. | Pitsiladis, Yannis, 1967- editor.
Title: Acute topics in anti-doping / volume editors, Olivier Rabin, Yannis Pitsiladis.
Other titles: Medicine and sport science ; v. 62. 0254-5020
Description: Basel, New York : Karger, [2017] | Series: Medicine and sport science, ISSN 0254-5020 ; vol. 62 | Includes bibliographical references and index.
Identifiers: LCCN 2017018114| ISBN 9783318060430 (hard cover : alk. paper) | ISBN 9783318060447 (e-ISBN)
Subjects: | MESH: Doping in Sports--prevention & control | Doping in Sports--legislation & jurisprudence
Classification: LCC RC1230 | NLM QT 262 | DDC 362.29/088796--dc23 LC record available at https://lccn.loc.gov/2017018114

Bibliographic Indices. This publication is listed in bibliographic services, including Current Contents ® and Index Medicus.
Disclaimer. The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publisher and the editor(s). The appearance of advertisements in the book is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Drug Dosage. The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any change in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
© Copyright 2017 by S. Karger AG, P.O. Box, CH–4009 Basel (Switzerland)
www.karger.com
Printed in Germany on acid-free and non-aging paper (ISO 9706)
ISSN 0254–5020
e-ISSN 1662–2812
ISBN 978–3–318–06043–0
e-ISBN 978–3–318–06044–7
Contents
Preface
Reedie, C. (Glasgow)

Brief History of Anti-Doping
Ljungqvist, A. (Stockholm)
Regulatory and Legal Issues
The Development of the World Anti-Doping Code
Young, R. (Colorado Springs, CO)
Is the Fight against Doping in Sport a Legal Minefield like Any Other?
Haas, U. (Zurich)
How Will the Legal and Sport Environment Influence a Future Code?
Niggli, O. (Montreal, QC)
The Anti-Doping Science
Structure and Development of the List of Prohibited Substances and Methods
Kinahan, A. (Montreal, QC/Ennis); Budgett, R. (Montreal, QC/London);
Mazzoni, I. (Montreal, QC/Dublin)
Therapeutic Use Exemptions
Gerrard, D. (Montreal, QC); Pipe, A. (Ottawa, ON)
Challenges in Modern Anti-Doping Analytical Science
Ayotte, C. (Laval, QC); Miller, J. (Glasgow); Thevis, M. (Cologne)
Achievements and Challenges in Anti-Doping Research
Bowers, L.D. (Colorado Springs, CO); Bigard, X. (Paris)
Gene and Cell Doping: The New Frontier – Beyond Myth or Reality
Neuberger, E.W.I.; Simon, P. (Mainz)
Next Generation Anti-Doping Approaches
The Athlete Biological Passport: How to Personalize Anti-Doping Testing across an Athlete’s Career?
Robinson, N. (Epalinges); Sottas, P.-E. (Lausanne); Schumacher, Y.O. (Doha)
Next Generation “Omics” Approaches in the “Fight” against Blood Doping
Wang, G. (Eastbourne/Rome); Karanikolou, A.; Verdouka I. (Eastbourne); Friedmann, T. (San Diego, CA); Pitsiladis, Y. (Eastbourne/Rome)
Integration of the Forensic Dimension into Anti-Doping Strategies
Marclay, F.; Saugy, M. (Epalinges/Lausanne)
How to Develop Intelligence Gathering in Efficient and Practical Anti-Doping Activities
Holz, M. (Lausanne); Robertson, J. (Montreal, QC)
Social and Ethical Dimensions of Anti-Doping
Education in Anti-Doping: The Art of Self-Imposed Constraints
Loland, S. (Oslo)
Can We Better Integrate the Role of Anti-Doping in Sports and Society? A Psychological Approach to Contemporary Value-Based Prevention
Petróczi, A. (Kingston upon Thames/Sheffield); Norman, P. (Sheffield); Brueckner, S. (Kingston upon Thames/Saarbrücken)
Sport, Society, and Anti-Doping Policy: An Ethical Overview
Bloodworth, A.J.; McNamee, M. (Swansea)
A Moral Foundation for Anti-Doping: How Far Have We Progressed? Where Are the Limits?
Murray, T.H. (Brewster, MA)

Conclusion and Perspectives
Howman, D. (Wellington)
Author Index
Subject Index
Preface
As we now operate under a revised and stronger version of the World Anti-Doping Code that came into force in January 2015, it is the appropriate time to provide the anti-doping community with an updated view of the approaches being taken to protect the clean athletes all around the world. This publication, edited by Olivier Rabin, the Science Director of the World Anti-Doping Agency (WADA), and Yannis Pitsiladis, a leading researcher, covers a wide range of issues including the revised regulatory framework, anti-doping science, possible future changes in emphasis, and the social and ethical dimensions of anti-doping, all entirely appropriate as we look towards the future.
WADA has become a major investor in anti-doping science and has invested since its inception close to USD 75 million. The opportunity now exists to develop this program further as governments around the world have provided some matching funding to meet the USD 10-million fund created by the International Olympic Committee (IOC). This is an exciting development and will widen the range of opportunities open to the scientific community to develop further new and potentially revolutionary processes necessary to protect sport and its athletes.
Progress of science and its implementation in routine anti-doping activities is pivotal in our strategy to expose doped athletes. That was particularly true at an individual level with the retesting program of samples collected by the IOC during the Beijing and London Olympic Games, which revealed more than a hundred new doping cases. Also, in 2016, the combination of science with intelligence and investigations revealed the proofs of the instituitonalized doping program in Russia.
Contributions to this volume of work come from some of the world leading experts in their fields of work and study and provide a wide-ranging picture of the current situation and future opportunities facing the anti-doping community. This is entirely relevant to the challenges faced and the efforts being made to advance the science and knowledge essential to the important tasks ahead.
I commend this book to the reader and thank all the contributors for their willingness to advance the cause of clean sport.
Sir Craig Reedie President of WADA
Rabin O, Pitsiladis Y (eds): Acute Topics in Anti-Doping. Med Sport Sci. Basel, Karger, 2017, vol 62, pp 1–10 DOI: 10.1159/000460680
______________________
Brief History of Anti-Doping
Arne Ljungqvist
Professor Arne Ljungqvist Anti-Doping Foundation, Stockholm, Sweden
______________________
Abstract
The fight against doping in sport as we know it today commenced by the creation of the International Olympic Committee (IOC) Medical Commission in 1961 following the death of a Danish cyclist during the Rome Olympic Games the year before. After a slow start, the fight got under way as from the early 1970s under the leadership of the IOC and of the International Association of Athletics Federations. Despite a lack of understanding and weak support even from the sports community, a series of measures were taken during the 1970s and 1980s which still form cornerstones of today’s anti-doping strategy. In addition to information and education campaigns, the most important examples are the introduction of procedural rules for doping controls, the establishment and follow-up of a list of prohibited substances and methods, the accreditation of doping control laboratories, the introduction of in- and out-of-competition testing, rules for therapeutic use exemption, and the introducti